Company: SCLXW
Filing Date: 2025-05-16
Form Type: DEF 14A
Source: 0000950170-25-073612
Chunk: 3

Company: Scilex Holding Co
Filing Date: 2025-05-16
Form: DEF 14A
Chunk 3
---
 not intended to be incorporated by reference into this Proxy Statement, and references to our website address in this Proxy Statement are inactive textual references only. What matters am I voting on? You will be voting on:

| • 
 • | the election of two Class III directors to serve until the 2028 annual meeting of stockholders and until their successors are duly elected and qualified; 
 the ratification of the appointment of BPM LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025; and     |
|:--|:----------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | any other business as may properly come before the Annual Meeting.                                                                                        |

How does the Board recommend I vote on these proposals? Our Board recommends a vote:

What if another matter is properly brought before the Annual Meeting? Our Board knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are properly brought before the Annual Meeting, it is the intention of the persons named in the accompanying proxy to vote on those matters in accordance with their best judgment. Who is entitled to vote? Holders of our common stock, par value $0.0001 per share (“Common Stock”), and holders of our Series A preferred stock, par value $0.0001 per share (“Series A Preferred Stock”), as of the close of business on May 15, 2025, the record date for the Annual Meeting (the “Record Date”), may vote at the Annual Meeting. The holders of Series A Preferred Stock are entitled to vote, together with the holders of Common Stock and not separately as a class, on an as converted to Common Stock basis, on all matters on which the holders of shares of Common Stock have the right to vote. As of the Record Date, there were 6,951,622 shares of our Common Stock and 29,057,097 shares of Series A

<div align='center'>5</div>

Preferred Stock outstanding. Stockholders are not permitted to cumulate votes with respect to the election of directors. Each share of Common Stock is entitled to one vote on each proposal. The 29,057,097 shares of Series A Preferred Stock outstanding are entitled to a number of votes as determined by dividing the stated value (as determined under our Certificate of Designations of Series A Preferred Stock, filed with the Delaware Secretary of State on November 10, 2022 (the “Certificate of Designations”)) by $10.00 and, as of the Record Date, such preferred